Drug reference

tildrakizumab-asmn

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1292

Overview

Names and pronunciation

(til-drakiz′ue-mab) Ilumya

PDF page 1292

Functional class

Func. class.: Antipsoriatic, interleukin- 23 inhibitor

PDF page 1292

Uses

USES: Treatment of adults with moderate to severe plaque psoriasis

PDF page 1292

Safety

Contraindications

CONTRAINDICATIONS Hypersensitivity

PDF page 1292

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Plaque psoriasis • Adult: SUBCUT: 100 mg at weeks 0, 4, and then q12wk

PDF page 1292

Available forms

Available forms: Injection 100 mg/mL single-dose syringe HIGH ALERT

PDF page 1292

Dose text by age group

Adult

• Adult: SUBCUT: 100 mg at weeks 0, 4, and then q12wk

PDF page 1292

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

tildrakizumab-asmn

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 1292

Overview

Names and pronunciation

(til-drakiz′ue-mab) Ilumya

PDF page 1292

Functional class

Func. class.: Antipsoriatic, interleukin- 23 inhibitor

PDF page 1292

Uses

USES: Treatment of adults with moderate to severe plaque psoriasis

PDF page 1292

Safety

Contraindications

CONTRAINDICATIONS Hypersensitivity

PDF page 1292

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Plaque psoriasis • Adult: SUBCUT: 100 mg at weeks 0, 4, and then q12wk

PDF page 1292

Available forms

Available forms: Injection 100 mg/mL single-dose syringe HIGH ALERT

PDF page 1292

Dose text by age group

Adult

• Adult: SUBCUT: 100 mg at weeks 0, 4, and then q12wk

PDF page 1292

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.